Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katleen De Preter

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Molecular & Cellular Oncology|May 28, 2019
DREAM target reactivation by core transcriptional regulators supports neuroblastoma growthBieke Decaesteker, Katleen De Preter, Frank Speleman
Seminars in Cancer Biology|August 16, 2011
Neuroblastoma genetics and phenotype: a tale of heterogeneityFrank Speleman, Katleen De Preter, Jo Vandesompele
Trends in Cancer|June 25, 2026
Multi-omics analysis of extracellular vesicle cargo in cancerAreti Georgiadi, Jarne Pauwels, Katleen De Preter, et al.
Bioinformatics (Oxford, England)|January 20, 2018
Computational deconvolution of transcriptomics data from mixed cell populationsFrancisco Avila Cobos, Jo Vandesompele, Pieter Mestdagh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 18, 2007
Detection of DNA copy number alterations in cancer by array comparative genomic hybridizationEvi Michels, Katleen De Preter, Nadine Van Roy, et al.
Frontiers in Bioinformatics|December 5, 2022
Opportunities and challenges in interpretable deep learning for drug sensitivity prediction of cancer cellsBikash Ranjan Samal, Jens Uwe Loers, Vanessa Vermeirssen, et al.
Nucleic Acids Research|March 19, 2008
Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regionsKatleen De Preter, Roland Barriot, Frank Speleman, et al.
Plos One|April 27, 2018
IncGraph: Incremental graphlet counting for topology optimisationRobrecht Cannoodt, Joeri Ruyssinck, Jan Ramon, et al.
The Lancet. Oncology|November 3, 2009
59-gene prognostic signature sub-stratifies high-risk neuroblastoma patientsJoëlle Vermeulen, Katleen De Preter, Geneviève Laureys, et al.
NPJ Systems Biology and Applications|February 15, 2024
Evaluation of single-sample network inference methods for precision oncologyJoke Deschildre, Boris Vandemoortele, Jens Uwe Loers, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Molecular & Cellular Oncology|May 28, 2019
DREAM target reactivation by core transcriptional regulators supports neuroblastoma growthBieke Decaesteker, Katleen De Preter, Frank Speleman
Seminars in Cancer Biology|August 16, 2011
Neuroblastoma genetics and phenotype: a tale of heterogeneityFrank Speleman, Katleen De Preter, Jo Vandesompele
Trends in Cancer|June 25, 2026
Multi-omics analysis of extracellular vesicle cargo in cancerAreti Georgiadi, Jarne Pauwels, Katleen De Preter, et al.
Bioinformatics (Oxford, England)|January 20, 2018
Computational deconvolution of transcriptomics data from mixed cell populationsFrancisco Avila Cobos, Jo Vandesompele, Pieter Mestdagh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 18, 2007
Detection of DNA copy number alterations in cancer by array comparative genomic hybridizationEvi Michels, Katleen De Preter, Nadine Van Roy, et al.
Frontiers in Bioinformatics|December 5, 2022
Opportunities and challenges in interpretable deep learning for drug sensitivity prediction of cancer cellsBikash Ranjan Samal, Jens Uwe Loers, Vanessa Vermeirssen, et al.
Nucleic Acids Research|March 19, 2008
Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regionsKatleen De Preter, Roland Barriot, Frank Speleman, et al.
Plos One|April 27, 2018
IncGraph: Incremental graphlet counting for topology optimisationRobrecht Cannoodt, Joeri Ruyssinck, Jan Ramon, et al.
The Lancet. Oncology|November 3, 2009
59-gene prognostic signature sub-stratifies high-risk neuroblastoma patientsJoëlle Vermeulen, Katleen De Preter, Geneviève Laureys, et al.
NPJ Systems Biology and Applications|February 15, 2024
Evaluation of single-sample network inference methods for precision oncologyJoke Deschildre, Boris Vandemoortele, Jens Uwe Loers, et al.
Pageof 14